Total Payments
$533,987
2024 Payments
$51,192
Companies
9
Transactions
690
Payment Breakdown by Category
Other$384,710 (72.0%)
Travel$82,349 (15.4%)
Consulting$46,855 (8.8%)
Food & Beverage$19,704 (3.7%)
Education$368.93 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $384,710 | 206 | 72.0% |
| Travel and Lodging | $82,349 | 170 | 15.4% |
| Consulting Fee | $46,855 | 17 | 8.8% |
| Food and Beverage | $19,704 | 293 | 3.7% |
| Education | $368.93 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $448,610 | 537 | $0 (2024) |
| ViiV Healthcare Company | $33,473 | 58 | $0 (2022) |
| Janssen Products, LP | $29,921 | 46 | $0 (2022) |
| Merck Sharp & Dohme LLC | $20,709 | 36 | $0 (2024) |
| Theratechnologies Inc. | $566.86 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $420.14 | 4 | $0 (2018) |
| AbbVie, Inc. | $124.10 | 1 | $0 (2017) |
| Alnylam Pharmaceuticals Inc. | $100.58 | 1 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $61.33 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51,192 | 65 | Gilead Sciences, Inc. ($45,886) |
| 2023 | $41,763 | 65 | Gilead Sciences, Inc. ($33,973) |
| 2022 | $34,842 | 52 | Gilead Sciences, Inc. ($26,414) |
| 2021 | $19,113 | 21 | Gilead Sciences, Inc. ($13,279) |
| 2020 | $44,396 | 42 | Gilead Sciences, Inc. ($36,351) |
| 2019 | $134,045 | 167 | Gilead Sciences, Inc. ($116,303) |
| 2018 | $103,809 | 137 | Gilead Sciences, Inc. ($84,329) |
| 2017 | $104,828 | 141 | Gilead Sciences Inc ($92,076) |
All Payment Transactions
690 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| 12/24/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $57.51 | General |
| 12/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $9.10 | General |
| 12/17/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $990.00 | General |
| Category: HIV | ||||||
| 12/10/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: HIV | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,715.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/20/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/14/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $50.00 | General |
| Category: HIV | ||||||
| 10/25/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,715.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/18/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Food and Beverage | In-kind items and services | $112.04 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/27/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| 09/25/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,286.25 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/23/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,360.00 | General |
| Category: HIV | ||||||
| 09/23/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,386.00 | General |
| 09/23/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.10 | General |
| 09/20/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $448.17 | General |
| Category: HIV | ||||||
| 09/20/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $354.42 | General |
| Category: HIV | ||||||
| 09/20/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Travel and Lodging | In-kind items and services | $202.00 | General |
| Category: HIV | ||||||
| 09/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $53.75 | General |
| 09/20/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: HIV | ||||||
| 09/05/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: HIV | ||||||
| 08/28/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $75.09 | General |
| Category: HIV | ||||||
| 07/26/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: HIV | ||||||
About Dr. John Hogan, M.D
Dr. John Hogan, M.D is a Gastroenterology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1114074838.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Hogan, M.D has received a total of $533,987 in payments from pharmaceutical and medical device companies, with $51,192 received in 2024. These payments were reported across 690 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($384,710).
Ad
Practice Information
- Specialty Gastroenterology
- Location Washington, DC
- Active Since 01/04/2007
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1114074838
Products in Payments
- Biktarvy (Drug) $179,313
- Truvada (Drug) $50,992
- Genvoya (Drug) $41,078
- Descovy (Drug) $37,967
- PIFELTRO (Drug) $18,743
- PREZCOBIX (Drug) $10,265
- Symtuza (Drug) $9,581
- DOVATO (Drug) $6,126
- CABENUVA (Drug) $4,600
- SYMTUZA (Drug) $2,024
- DELSTRIGO (Drug) $1,857
- JULUCA (Drug) $1,149
- EGRIFTA (Drug) $450.12
- TIVICAY (Drug) $202.46
- TRIUMEQ (Drug) $127.73
- Mavyret (Drug) $124.10
- Epclusa (Drug) $120.80
- EGRIFTA SV (Drug) $116.74
- ZEPATIER (Drug) $108.50
- Sunlenca (Drug) $43.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Washington
James Lewis
Gastroenterology — Payments: $1.2M
Gastroenterology $1.2M
Dr. Mark Mattar, Md, MD
Gastroenterology — Payments: $385,054
Gastroenterology $385,054
Jessica Korman, M.d, M.D
Gastroenterology — Payments: $114,919
Gastroenterology $114,919
Dr. Roshan Bashir, M.d, M.D
Gastroenterology — Payments: $61,004
Gastroenterology $61,004
Dr. Dominique Howard, M.d, M.D
Gastroenterology — Payments: $27,909
Gastroenterology $27,909
Lauren George, M.d, M.D
Gastroenterology — Payments: $24,323
Gastroenterology $24,323